Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sorrento Therapeutics Inc (NASDAQ:SRNE)

1.75
Delayed Data
As of May 26
 +0.10 / +6.06%
Today’s Change
1.55
Today|||52-Week Range
8.35
-64.29%
Year-to-Date
No recent news for Sorrento Therapeutics Inc.

Today’s Trading

Previous close1.65
Today’s open1.60
Day’s range1.60 - 1.75
Volume404,508
Average volume (3 months)617,167
Market cap$131.8M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)+2.42%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+77.60%
P/E ratioNM
Price/Sales30.27
Price/Book0.95

Competitors

 Today’s
change
Today’s
% change
BDSIBioDelivery Sciences...+0.20+9.09%
SBPHSpring Bank Pharmace...-0.15-1.08%
--China Health Group I...+0.00+2.96%
CRMECardiome Pharma Corp+0.20+4.84%
Data as of 3:59pm ET, 05/26/2017

Financials

Last reporting dateMarch 1, 2017
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$8.2M
Annual profit (last year)-$60.9M
Net profit margin-747.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Henry H. Ji
Chief Operating Officer &
Executive Vice President
Jeffrey Su
Corporate headquarters
San Diego, California

Forecasts